Title: Miho Ogawa - Innovator in Health and Biotechnology
Introduction
Miho Ogawa is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the fields of health and biotechnology. Although she currently holds no granted patents, her innovative work continues to impact the industry.
Latest Patent Applications
Miho Ogawa's latest patent applications include:
1. **Anti-Human Coronavirus Composition** - The objective of this invention is to provide a non-pharmaceutical anti-human coronavirus composition that prevents human coronavirus infections, the onset of the infections, or aggravation of symptoms of the infections. The composition includes an exopolysaccharide produced by a lactic acid bacterium in the genus, which may belong to a specific species, particularly subsp. OLL1073R-1 (FERM BP-10741).
2. **In Vitro Growth Method for Hair Follicular Epithelial Stem Cells** - This application aims to provide means for the efficient growth of epithelial cells capable of being used to manufacture regenerated hair follicle germs. It includes a culture medium comprising a basal medium and at least one species of BMP inhibitor, fibroblast growth factor, and sonic hedgehog (SHH) or SHH agonist.
Conclusion
Miho Ogawa's work exemplifies the spirit of innovation in health and biotechnology. Her contributions, particularly in the development of anti-coronavirus compositions and hair follicle regeneration methods, highlight her commitment to advancing scientific knowledge and improving health outcomes.